Cargando…
Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort
BACKGROUND: Betamethasone, a glucocorticoid used to induce lung maturation when there is a risk of preterm delivery, can affect the immune system maturation and type 1 diabetes (T1D) incidence in the progeny. It has been described that prenatal betamethasone protects offspring from experimental T1D...
Autores principales: | Perna-Barrull, David, Murillo, Marta, Real, Nati, Gomez-Muñoz, Laia, Rodriguez-Fernandez, Silvia, Bel, Joan, Puig-Domingo, Manel, Vives-Pi, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930272/ https://www.ncbi.nlm.nih.gov/pubmed/35308094 http://dx.doi.org/10.1155/2022/6598600 |
Ejemplares similares
-
Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes
por: Perna-Barrull, David, et al.
Publicado: (2020) -
Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes
por: Perna-Barrull, David, et al.
Publicado: (2019) -
Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells
por: Perna-Barrull, David, et al.
Publicado: (2022) -
Prenatal Administration of Betamethasone Causes Changes in the T Cell Receptor Repertoire Influencing Development of Autoimmunity
por: Gieras, Anna, et al.
Publicado: (2017) -
Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential
por: Rodriguez-Fernandez, Silvia, et al.
Publicado: (2019)